Candel Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 42
- Market Cap
- -
- Website
- http://www.candeltx.com
- Introduction
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Candel Therapeutics, Inc. SEC 10-Q Report
Candel Therapeutics' Q3 2024 report highlights financial performance, business operations, and strategic initiatives, including advancing clinical trials for CAN-2409 and CAN-3110, receiving FDA designations, and collaborations with the University of Pennsylvania. The company faces financial and operational risks, necessitating additional funding and strategic focus on key clinical programs.
© Copyright 2024. All Rights Reserved by MedPath